VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −2 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 10.53M | +5.6% | $186.66M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 451.87K | +24.6% | $7.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 9.23K | +11.1% | $161,149 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Robeco Institutional Asset… | $33.04M | was 0.0% |
| Assetmark, Inc | $175,320 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,011 holders, 984.50M shares, $12.02B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.